| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.042 | 0.8 |